Reading view
The Responsibility Vacuum: Organizational Failure in Scaled Agent Systems
An Optimized Decision Tree-Based Framework for Explainable IoT Anomaly Detection
Towards Execution-Grounded Automated AI Research
Automated Rubrics for Reliable Evaluation of Medical Dialogue Systems
Manalyzer: End-to-end Automated Meta-analysis with Multi-agent System
Large language models improve transferability of electronic health record-based predictions across countries and coding systems
npj Digital Medicine, Published online: 22 January 2026; doi:10.1038/s41746-026-02363-5
Large language models improve transferability of electronic health record-based predictions across countries and coding systemsMultimodal AI generates virtual population for tumor microenvironment modeling
STAT+: OpenEvidence raises $250 million, doubling its valuation
OpenEvidence, maker of a popular chatbot that helps doctors search clinical evidence, on Wednesday announced $250 million in new funding.
The new round led by Thrive Capital and DST Global values OpenEvidence at $12 billion, and the company has announced $735 million in funding in the last 12 months. OpenEvidence is free to use by any clinician with a national provider identifier number. The companyβs primary business model is advertising shown to clinicians.Β
Founded in 2022, OpenEvidence is one of the most prominent and best-funded companies from a wave of health artificial intelligence companies that emerged since the widespread availability of large language models. Reflecting on the eye-popping fundraising for health AI, a Silicon Valley Bank report released earlier in January raised an eyebrow at the ability of companies like OpenEvidence to deliver on their stratospheric valuations with advertising and software-as-a-service business models. βIt wonβt be a surprise to see them tap the value of the data theyβre already collectingβ to offer more services to pharma or other customers, the authors wrote.
Continue to STAT+ to read the full storyβ¦


Β© Adobe